The Advisory Committee on Immunization Practices (ACIP) at the CDC voted unanimously to allow all fully vaccinated adults to receive a COVID-19 booster at least six months after receiving a primary series. All 11 members of the panel also voted on Nov. 19 to recommend boosters for adults 50 and older. Last week, FDA authorized…
ACIP votes unanimously backs GSK’s shingles vaccine Shingrix for immunocompromised adults 19 and older
CDC’s Advisory Committee on Immunization Practices (ACIP) unanimously recommended two doses of GlaxoSmithKline’s (NYSE:GSK) Shingrix (a recombinant adjuvanted zoster vaccine) for adults 19 and older with immunodeficiency or immunosuppression as a result of disease or therapy. CDC considers Shingrix to be an adult vaccine, and its recommendation is for the adult immunization schedule, which begins…
Vaccine panel postpones vote on J&J COVID-19 vaccine
A CDC advisory committee decided not to vote on how Johnson & Johnson’s COVID-19 vaccine should be deployed, reasoning that it needs more time to review data related to rare blood clots potentially linked to the vaccine. The CDC and FDA announced on April 13 their recommendation to pause the vaccine’s use on safety grounds.…
Who should get COVID-19 vaccines first? CDC advisors have ideas
An estimated 21 million U.S. healthcare workers should be among the first to receive a COVID-19 vaccine, according to a CDC advisory committee. The Advisory Committee on Immunization Practices (ACIP) within the CDC met yesterday to discuss how to best allocate COVID-19 vaccines. Members of the group will formalize their recommendations by voting after FDA…